Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think! opens in new tab/window

Elsevier
Publish with us

Early Career Researcher Award Winner

David R. Martinez

DRM

David R. Martinez

Yale University School of Medicine, USA

Early Career Researcher Award Winner

David R. Martinez, Yale University School of Medicine, USA

David R. Martinez, Ph.D. studies immunity to viral pathogens of global health importance. David Martinez received his Ph.D. from Duke University in the laboratory of leading vaccine immunologist, Dr. Sallie Permar. David Martinez trained as a postdoctoral scholar with one the world’s leading coronavirologists, Dr. Ralph Baric, at UNC Chapel Hill before and during the COVID-19 pandemic studying immunity to flaviviruses and coronaviruses. David Martinez was part of the teams that contributed to the development of the FDA-approved and widely used Moderna COVID-19 vaccine. David Martinez also contributed to the pre-clinical development of COVID-19 human monoclonal antibody therapies used in humans. David Martinez is a Hanna Gray Faculty Fellow of the Howard Hughes Medical Institute. In 2023, David Martinez began his laboratory in the Department of Immunobiology at Yale University School of Medicine.